We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
Intravenous and oral etoposide ( VP 16-213) were tested in two sequential phase II trials in chemotherapy-naive patients with malignant pleural mesothelioma.